<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03929263</url>
  </required_header>
  <id_info>
    <org_study_id>CHS2017011</org_study_id>
    <nct_id>NCT03929263</nct_id>
  </id_info>
  <brief_title>Parent-Adolescent Training on Neurofeedback and Synchrony</brief_title>
  <official_title>The Dyadic Inter-Brain Signaling (DIBS) Project With Parent-Adolescent Training on Neurofeedback and Synchrony</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oklahoma State University Center for Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oklahoma State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oklahoma State University Center for Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will test a real-time functional magnetic resonance imaging (fMRI) hyperscanning&#xD;
      neurofeedback protocol for feasibility with ten mothers and their psychiatrically healthy&#xD;
      adolescent daughters, with the eventual goal to test this in a sample of depressed&#xD;
      adolescents in a future study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will utilize a rigorous multi-method, multi-informant design to examine the&#xD;
      effects of dyadic neurofeedback (dnf) on adolescent brain activation with fMRI hyperscanning.&#xD;
      Parents and adolescents will also report on emotion regulation, depressive symptoms, and&#xD;
      parenting practices. Data collection procedures will take place at the Laureate Institute for&#xD;
      Brain Research (LIBR), which is equipped with two identical scanners that have advanced&#xD;
      real-time fMRI systems capable of conducting parallel fMRI hyperscanning, including the&#xD;
      capacity for neurofeedback. Parents will complete a phone screen to determine initial&#xD;
      eligibility. If initial study criteria are met, a 2-hour in-person lab visit will be&#xD;
      scheduled where mothers and daughters will complete consent/assent; diagnostic interviews;&#xD;
      surveys on emotion regulation, parenting practices, depression, and anxiety; and additional&#xD;
      screening. Survey data will be used for preliminary exploratory analyses. Based on data&#xD;
      collected from the screening visit, participants will be invited to participate in the full&#xD;
      study: a 4-hour visit where mothers and daughters will complete emotion ratings, mock scanner&#xD;
      training, and fMRI tasks individually and together using hyperscanning (scan time = 16 min&#xD;
      resting-state [2 runs], 7 min structural MRI, 40 min fMRI tasks, 10 min clinical MRI scans).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 25, 2019</start_date>
  <completion_date type="Actual">February 27, 2021</completion_date>
  <primary_completion_date type="Actual">February 27, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neurofeedback Rating Scale</measure>
    <time_frame>Baseline (Acquired during scan session)</time_frame>
    <description>Rating scale of perceived effectiveness in completing the task and changing brain activation. Likert scale ranging from 0-10, with higher numbers indicating greater perceived effectiveness.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Emotion Rating Scale</measure>
    <time_frame>Baseline (Acquired during scan session)</time_frame>
    <description>Rating scale asking about current experience of various emotions (happy, sad, angry, etc.). Scale ranges from 0-10, with higher numbers indicating more intense emotions.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood Oxygen Level-Dependent (BOLD) Signal Changes (Brain Activation)</measure>
    <time_frame>Baseline (Acquired during scan session)</time_frame>
    <description>Activation in the brain region targeted for neurofeedback and associated regions; resting-state network activity</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Testing Protocol With Healthy Individuals for Feasibility</condition>
  <arm_group>
    <arm_group_label>Real-time fMRI neurofeedback</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants will receive neurofeedback from the target region (no sham condition).</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Real-time fMRI neurofeedback</intervention_name>
    <description>Participants will attempt to regulate own and/or their partner's brain activation in a specified brain region via real-time fMRI neurofeedback.</description>
    <arm_group_label>Real-time fMRI neurofeedback</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Eligible for fMRI&#xD;
&#xD;
          -  Sufficient English fluency to complete tasks&#xD;
&#xD;
          -  BMI ≦ 40.0&#xD;
&#xD;
          -  Right-handed&#xD;
&#xD;
          -  Biological female&#xD;
&#xD;
          -  Co-residing at least 4 days/week&#xD;
&#xD;
          -  Adult participants: Biological mother of adolescent participant&#xD;
&#xD;
          -  Adult participants:Primary caregiver &gt; 50% of child's lifespan&#xD;
&#xD;
          -  Adult participants:BMI ≧ 18.0&#xD;
&#xD;
          -  Adolescent participants: Age 13-17 years&#xD;
&#xD;
          -  Adolescent participants: BMI ≧ 16.0&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current psychiatric diagnosis&#xD;
&#xD;
          -  Medications influencing fMRI&#xD;
&#xD;
          -  Medical conditions influencing fMRI&#xD;
&#xD;
          -  Alcohol or psychoactive drug on scan day&#xD;
&#xD;
          -  Adolescent participants: Neurodevelopmental delay&#xD;
&#xD;
          -  Adolescent participants: History of mood or psychotic disorder&#xD;
&#xD;
          -  Adolescent participants: History of obsessive-compulsive disorder (OCD) or&#xD;
             attention-deficit/hyperactivity disorder (ADHD)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kara L Kerr, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oklahoma State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laureate Institute for Brain Research</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>April 22, 2019</study_first_submitted>
  <study_first_submitted_qc>April 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2019</study_first_posted>
  <last_update_submitted>June 25, 2021</last_update_submitted>
  <last_update_submitted_qc>June 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

